Case Western Reserve University developed the gadolinium material, which is expected to be tested in 30 healthy participants beginning later this month.
The Nobody Left Behind or NOBLE Registry aims to establish prostate-specific membrane antigen SPECT imaging as a cost-effective and widely available alternative to PSMA-PET.
Private equity acquisitions and consolidation are making it difficult for such practices to compete, but going above and beyond for patients and referrers can bring a strategic advantage.